← Leaderboards
David L Tait
Vanderbilt University
$0
Attributed
$0
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 1
By mechanism
M01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Barney S Graham$269,836
- Nancy Joan Brown$32,445,188
- David Herlie Robertson$14,232,685
- Stephen N. Davis$16,024,395
- Grant R. Wilkinson$1,933,364
Others in their field
Top investigators on “Brca Gene”
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$11,731,263
- Alan David D'andrea · Dana-Farber Cancer Inst$9,947,483
- Timothy R Rebbeck · Dana-Farber Cancer Inst$9,839,795
- Robert C Bast · University Of Texas Md Anderson Can Ctr$8,625,084
- Tomasz Skorski · Temple Univ Of The Commonwealth$8,413,060
- Titia De Lange · Rockefeller University$8,275,634
Research focus
Brca GeneClinical ResearchGene TherapyHuman SubjectHuman Therapy EvaluationNeoplasm /Cancer TherapyOvary NeoplasmsRetroviridaeTransfection /Expression Vector
Grant awards (5)
BRCA I GENE THERAPY FOR OVARIAN CANCER--A PHASE II TRIAL$0
M01 · FY2002 · RR
BRCA I GENE THERAPY FOR OVARIAN CANCER--A PHASE II TRIAL$0
M01 · FY2001 · RR
BRCA I GENE THERAPY FOR OVARIAN CANCER--A PHASE II TRIAL$0
M01 · FY2001 · RR
BRCA I GENE THERAPY FOR OVARIAN CANCER--A PHASE II TRIAL$0
M01 · FY2001 · RR
BRCA I GENE THERAPY FOR OVARIAN CANCER--A PHASE II TRIAL$0
M01 · FY2000 · RR